Table 3.

Results of multivariate Cox analyses (n = 155)

VariableParameter estimateSEPHR
Overall survival
BRCA vs. NH0.7250.2840.012.07
 Platinum sensitive vs. platinum resistant0.4570.2690.091.58
 Age at diagnosis (change per year)0.0060.0110.601.01
 PLD second line vs. third line−0.1900.2360.420.83
 PLD-platinum combination vs. PLD alone−0.2780.2510.270.76
Time to treatment failure
BRCA vs. NH0.5040.2200.021.67
 Platinum sensitive vs. platinum resistant0.2350.2210.281.26
 Age at diagnosis (change per year)0.0070.0090.441.01
 PLD second line vs. third line−0.2900.1900.140.75
 PLD-platinum combination vs. PLD alone0.1770.1870.341.19

Abbreviations: HR, hazard ratio; NH, nonhereditary; PLD, pegylated liposomal doxorubicin.